I have this horrible feeling that even if we get equivalence with Dapto in the Phase 2b trial,... that the price will pop but then the selling will continue and we will end up returing to below $2.00.
It is relentless and it seems to me even with an additional few days of a million of so shares traded that it will not be enough to get us and hold us over the $2.00 mark.
I'm not 100% sure who is selling and keeping us down,.. could be Aspire, could be the traders here, could be the competition,... could be a combination of any of these, or something none of us have hinted at before.
I feel only when Leo finalizes a deal with a large Pharma that will include Financial freedom for, us will our price reach and hold a new level to where we can get to a new exchange.
That might be months after the Phase 2b results are announced. I hope that Leo can expedite that deal as quickly as possible,... like the next day after the results are in.
Looking foward to the R&R hoping we will at least get how many patients did how many cycles, especially now that we are in the higher levels of the drug.
Market Data 
Markets 
AI
